Literature DB >> 33136743

Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.

Andrew T Boyd1, Bethrand Odume2,3, Kassim Sidibe1, Dennis Onotu2, Obinna Ogbanufe2, Ifunanya Mgbakor2, Mahesh Swaminathan2.   

Abstract

BACKGROUND: Tuberculosis preventive treatment (TPT) is a critical intervention to reduce tuberculosis mortality among people living with HIV (PLHIV). To facilitate scale-up of TPT among PLHIV, the Nigeria Ministry of Health and the US Centers for Disease Control and Prevention (CDC) Nigeria, supported by US President's Emergency Plan for AIDS Relief implementing partners, launched a TPT-focused technical assistance strategy in high-volume antiretroviral treatment (ART) sites during 2018.
SETTING: Nigeria has an estimated 1.9 million PLHIV, representing the second largest national burden of PLHIV in the world, and an estimated 53% of PLHIV are on ART.
METHODS: In 50 high-volume ART sites, we assessed readiness for TPT scale-up through use of a standardized tool across the following 5 areas: clinical training, community education, patient management, commodities and logistics management, and recording and reporting. We deployed a site-level continuous quality improvement strategy to facilitate TPT scale-up. Implementing partners rapidly disseminated best practices from these sites to across all CDC-supported sites and reported aggregate data on monthly TPT initiations.
RESULTS: Through this targeted assistance and rapid dissemination of best practices to all other sites, the number of PLHIV who initiated TPT across all CDC-supported sites increased from 6622 in May 2018, when the approach was implemented, to 48,661 in September 2018. Gains in monthly TPT initiations were sustained through March 2019.
CONCLUSIONS: Use of a standardized tool for assessing readiness for TPT scale-up provided a "checklist" of potential barriers to TPT scale-up to address at each site. The quality improvement approach allowed each site to design a specific plan to achieve desired TPT scale-up, and best practices were implemented concurrently at other, smaller sites. The approach could assist scale-up of TPT among PLHIV in other countries.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33136743      PMCID: PMC7788685          DOI: 10.1097/QAI.0000000000002483

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  6 in total

1.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

Authors:  Christine Danel; Raoul Moh; Delphine Gabillard; Anani Badje; Jérôme Le Carrou; Timothée Ouassa; Eric Ouattara; Amani Anzian; Jean-Baptiste Ntakpé; Albert Minga; Gérard M Kouame; Franck Bouhoussou; Arlette Emieme; Antoine Kouamé; André Inwoley; Thomas-d'Aquin Toni; Hugues Ahiboh; Mathieu Kabran; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Romuald Konan; Joachim Gnokoro; Patrice Gouesse; Eugène Messou; Lambert Dohoun; Synali Kamagate; Abo Yao; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Yao Ndri; Olivier Ba-Gomis; Marcelle Daligou; Simplice Ackoundzé; Denise Hawerlander; Alex Ani; Fassery Dembélé; Fatoumata Koné; Calixte Guéhi; Constance Kanga; Serge Koule; Jonas Séri; Mykayila Oyebi; Nathalie Mbakop; Olewole Makaila; Carole Babatunde; Nathanael Babatounde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Rodrigue Assi; Alima Bakayoko; Alassane Mahassadi; Alain Attia; Armel Oussou; Max Mobio; Doféré Bamba; Mesmin Koman; Apollinaire Horo; Nina Deschamps; Henri Chenal; Madeleine Sassan-Morokro; Seidou Konate; Kakou Aka; Eba Aoussi; Valérie Journot; Célestin Nchot; Sophie Karcher; Marie-Laure Chaix; Christine Rouzioux; Papa-Salif Sow; Christian Perronne; Pierre-Marie Girard; Hervé Menan; Emmanuel Bissagnene; Auguste Kadio; Virginie Ettiegne-Traore; Corinne Moh-Semdé; Abo Kouame; Jean-Marie Massumbuko; Geneviève Chêne; Mireille Dosso; Serge K Domoua; Thérèse N'Dri-Yoman; Roger Salamon; Serge P Eholié; Xavier Anglaret
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

2.  TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings.

Authors:  I Pathmanathan; S Ahmedov; E Pevzner; G Anyalechi; S Modi; H Kirking; J S Cavanaugh
Journal:  Int J Tuberc Lung Dis       Date:  2018-06-01       Impact factor: 2.373

3.  Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

Authors:  Anani Badje; Raoul Moh; Delphine Gabillard; Calixte Guéhi; Mathieu Kabran; Jean-Baptiste Ntakpé; Jérôme Le Carrou; Gérard M Kouame; Eric Ouattara; Eugène Messou; Amani Anzian; Albert Minga; Joachim Gnokoro; Patrice Gouesse; Arlette Emieme; Thomas-d'Aquin Toni; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Lambert Dohoun; Abo Yao; Synali Kamagate; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Marcelle Daligou; Denise Hawerlander; Simplice Ackoundzé; Serge Koule; Jonas Séri; Alex Ani; Fassery Dembélé; Fatoumata Koné; Mykayila Oyebi; Nathalie Mbakop; Oyewole Makaila; Carolle Babatunde; Nathaniel Babatunde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Sophie Karcher; Christine Rouzioux; Abo Kouame; Rodrigue Assi; Alima Bakayoko; Serge K Domoua; Nina Deschamps; Kakou Aka; Thérèse N'Dri-Yoman; Roger Salamon; Valérie Journot; Hughes Ahibo; Timothée Ouassa; Hervé Menan; André Inwoley; Christine Danel; Serge P Eholié; Xavier Anglaret
Journal:  Lancet Glob Health       Date:  2017-11       Impact factor: 26.763

4.  Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision.

Authors:  S C Meribe; Y Adamu; E Adebayo-Abikoye; I Lawal; I Amazue-Ezeuko; N Okeji; I Okoye; P Agaba; R Nelson; E Lee; L Chittenden
Journal:  Public Health Action       Date:  2020-06-21

5.  Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience.

Authors:  B Odume; S C Meribe; T Odusote; M Ifunanya; H Debem; I Amazue-Ezeuko; O Ogbanufe; Y Adamu; D Onotu
Journal:  Public Health Action       Date:  2020-03-21

Review 6.  Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors:  Henok Tadesse Ayele; Maaike S M van Mourik; Thomas P A Debray; Marc J M Bonten
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.